Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 3546 entries
View as:

Darapladib China PK

Phase: N/A Priority: Normal
NCT ID: NCT02000804 Org: User:
Start: 10/23/13 End: 01/04/14 Due: 01/04/15

A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive

Phase: N/A Priority: Normal
NCT ID: NCT06433908 Org: User:
Start: 06/04/24 End: 10/22/24 Due: 10/22/25

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01090453 Org: User:
Start: 05/17/10 End: 10/11/11 Due: 10/11/12

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

Phase: N/A Priority: Normal
NCT ID: NCT02130193 Org: User:
Start: 02/13/14 End: 08/29/16 Due: 08/29/17

An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand

Phase: N/A Priority: Normal
NCT ID: NCT00814957 Org: User:
Start: 12/08/08 End: 06/11/09 Due: 06/11/10

A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

Phase: N/A Priority: Normal
NCT ID: NCT03014674 Org: User:
Start: 01/06/17 End: 08/11/17 Due: 08/11/18

Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 11-17 Year-Old Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00464815 Org: User:
Start: 05/02/07 End: 09/10/08 Due: 09/10/09

Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00146835 Org: User:
Start: 04/30/03 End: 06/30/06 Due: 06/30/07

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00989287 Org: User:
Start: 10/07/09 End: 10/26/10 Due: 10/26/11

Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00097331 Org: User:
Start: 09/30/04 End: 07/31/06 Due: 07/31/07

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Phase: N/A Priority: Normal
NCT ID: NCT00400335 Org: User:
Start: 10/31/06 End: - Due: -

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00197197 Org: User:
Start: 07/31/05 End: 10/31/05 Due: 10/31/06

Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis

Phase: N/A Priority: Normal
NCT ID: NCT00137930 Org: User:
Start: 08/31/05 End: 11/30/05 Due: 11/30/06

Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01610427 Org: User:
Start: 06/25/12 End: 10/30/12 Due: 10/30/13

Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT01506193 Org: User:
Start: 02/06/12 End: 03/31/14 Due: 03/31/15

Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib

Phase: N/A Priority: Normal
NCT ID: NCT00652951 Org: User:
Start: 04/01/08 End: 12/01/10 Due: 12/01/11

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT01949090 Org: User:
Start: 09/25/13 End: 10/23/14 Due: 10/23/15

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

Phase: N/A Priority: Normal
NCT ID: NCT00320424 Org: User:
Start: 02/16/06 End: 10/26/06 Due: 10/26/07

Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™

Phase: N/A Priority: Normal
NCT ID: NCT01435967 Org: User:
Start: 09/30/11 End: 09/30/14 Due: 09/30/15

Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK

Phase: N/A Priority: Normal
NCT ID: NCT00995995 Org: User:
Start: 10/31/08 End: 02/28/09 Due: 02/28/10

A Study to Investigate Efficacy of Two Experimental Oral Rinses in Providing Long Term Relief From Pain Derived From Exposed Dentine in Response to Chemical, Thermal, Tactile, or Osmotic Stimuli.

Phase: N/A Priority: Normal
NCT ID: NCT02651467 Org: User:
Start: 01/04/16 End: 04/22/16 Due: 04/22/17

Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015

Phase: N/A Priority: Normal
NCT ID: NCT02885246 Org: User:
Start: 09/11/17 End: 09/17/18 Due: 09/17/19

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing

Phase: N/A Priority: Normal
NCT ID: NCT01669083 Org: User:
Start: 08/16/12 End: 03/09/13 Due: 03/09/14

Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women

Phase: N/A Priority: Normal
NCT ID: NCT00326248 Org: User:
Start: 03/31/06 End: 07/31/06 Due: 07/31/07

Enamel Remineralization Potential of Dentifrices in Situ

Phase: N/A Priority: Normal
NCT ID: NCT01128946 Org: User:
Start: 11/30/09 End: 03/31/10 Due: 03/31/11